Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction

Christopher D. Aluise; Rukhsana Sultana; Jitbangjong Tangpong; Mary Vore; Daret St. Clair; Jeffrey A. Moscow; D. Allan Butterfield

doi:10.1007/978-1-4419-6306-2_19

Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction

Christopher D. Aluise
, Rukhsana Sultana
, Jitbangjong Tangpong
, Mary Vore
, Daret St. Clair
, Jeffrey A. Moscow
, D. Allan Butterfield

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

107 Scopus citations

Abstract

Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.

Original language	English
Title of host publication	Chemo Fog
Subtitle of host publication	Cancer Chemotherapy-Related Cognitive Impairment
Editors	Robert Raffa, Ronald Tallarida
Pages	147-156
Number of pages	10
DOIs	https://doi.org/10.1007/978-1-4419-6306-2_19
State	Published - 2010

Publication series

Name	Advances in Experimental Medicine and Biology
Volume	678
ISSN (Print)	0065-2598

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/978-1-4419-6306-2_19

Cite this

Aluise, C. D., Sultana, R., Tangpong, J., Vore, M., St. Clair, D., Moscow, J. A., & Butterfield, D. A. (2010). Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. In R. Raffa, & R. Tallarida (Eds.), Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment (pp. 147-156). (Advances in Experimental Medicine and Biology; Vol. 678). https://doi.org/10.1007/978-1-4419-6306-2_19

Aluise, Christopher D. ; Sultana, Rukhsana ; Tangpong, Jitbangjong et al. / Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration : Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment. editor / Robert Raffa ; Ronald Tallarida. 2010. pp. 147-156 (Advances in Experimental Medicine and Biology).

@inbook{90d8a01af60944b4bb4b7466e1332973,

title = "Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction",

abstract = "Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.",

author = "Aluise, \{Christopher D.\} and Rukhsana Sultana and Jitbangjong Tangpong and Mary Vore and \{St. Clair\}, Daret and Moscow, \{Jeffrey A.\} and Butterfield, \{D. Allan\}",

year = "2010",

doi = "10.1007/978-1-4419-6306-2\_19",

language = "English",

isbn = "9781441963055",

series = "Advances in Experimental Medicine and Biology",

pages = "147--156",

editor = "Robert Raffa and Ronald Tallarida",

booktitle = "Chemo Fog",

}

Aluise, CD, Sultana, R, Tangpong, J, Vore, M, St. Clair, D, Moscow, JA & Butterfield, DA 2010, Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. in R Raffa & R Tallarida (eds), Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment. Advances in Experimental Medicine and Biology, vol. 678, pp. 147-156. https://doi.org/10.1007/978-1-4419-6306-2_19

Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. / Aluise, Christopher D.; Sultana, Rukhsana; Tangpong, Jitbangjong et al.
Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment. ed. / Robert Raffa; Ronald Tallarida. 2010. p. 147-156 (Advances in Experimental Medicine and Biology; Vol. 678).

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

TY - CHAP

T1 - Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration

T2 - Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction

AU - Aluise, Christopher D.

AU - Sultana, Rukhsana

AU - Tangpong, Jitbangjong

AU - Vore, Mary

AU - St. Clair, Daret

AU - Moscow, Jeffrey A.

AU - Butterfield, D. Allan

PY - 2010

Y1 - 2010

N2 - Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.

AB - Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.

UR - https://www.scopus.com/pages/publications/77956633238

UR - https://www.scopus.com/pages/publications/77956633238#tab=citedBy

U2 - 10.1007/978-1-4419-6306-2_19

DO - 10.1007/978-1-4419-6306-2_19

M3 - Chapter

C2 - 20738017

AN - SCOPUS:77956633238

SN - 9781441963055

T3 - Advances in Experimental Medicine and Biology

SP - 147

EP - 156

BT - Chemo Fog

A2 - Raffa, Robert

A2 - Tallarida, Ronald

ER -

Aluise CD, Sultana R, Tangpong J, Vore M, St. Clair D, Moscow JA et al. Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. In Raffa R, Tallarida R, editors, Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment. 2010. p. 147-156. (Advances in Experimental Medicine and Biology). doi: 10.1007/978-1-4419-6306-2_19

Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration: Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction

Abstract

Publication series

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this